Improving Outcomes in Inflammatory Bowel Diseases. Module C. D.
While IBD consists of chronic and often difficult diseases, it can be managed with a combination of proper pharmaceutical treatments and, just as important, a commitment to a treatment plan. This module begins by looking at the most common pharmaceutical treatments, such as 5-ASA compounds and corticosteroids, which can help with inflammation due to IBD; and biologic agents, which act as anti-tumor necrosis factor agents. The module then details the pros and cons of various pharmaceuticals, in terms of benefits and possible side effects, such as skin problems and increased vulnerability to infection. Finally, the module looks at adjunct treatments, such as anti-spasmodics or anti-diarrheal medications, though some are used off-label for UC and CD.